Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

67 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Phase II trial of trastuzumab in women with advanced or recurrent, HER2-positive endometrial carcinoma: a Gynecologic Oncology Group study.
Fleming GF, Sill MW, Darcy KM, McMeekin DS, Thigpen JT, Adler LM, Berek JS, Chapman JA, DiSilvestro PA, Horowitz IR, Fiorica JV. Fleming GF, et al. Among authors: horowitz ir. Gynecol Oncol. 2010 Jan;116(1):15-20. doi: 10.1016/j.ygyno.2009.09.025. Epub 2009 Oct 18. Gynecol Oncol. 2010. PMID: 19840887 Free PMC article. Clinical Trial.
Evaluation of monoclonal humanized anti-HER2 antibody, trastuzumab, in patients with recurrent or refractory ovarian or primary peritoneal carcinoma with overexpression of HER2: a phase II trial of the Gynecologic Oncology Group.
Bookman MA, Darcy KM, Clarke-Pearson D, Boothby RA, Horowitz IR. Bookman MA, et al. Among authors: horowitz ir. J Clin Oncol. 2003 Jan 15;21(2):283-90. doi: 10.1200/JCO.2003.10.104. J Clin Oncol. 2003. PMID: 12525520 Clinical Trial.
Phase I trial of escalating doses of paclitaxel combined with fixed doses of cisplatin and doxorubicin in advanced endometrial cancer and other gynecologic malignancies: a Gynecologic Oncology Group study.
Fleming GF, Fowler JM, Waggoner SE, Copeland LJ, Greer BE, Horowitz I, Sutton G, Schilder RJ, Fracasso PM, Ball HG, McGuire WP 3rd. Fleming GF, et al. J Clin Oncol. 2001 Feb 15;19(4):1021-9. doi: 10.1200/JCO.2001.19.4.1021. J Clin Oncol. 2001. PMID: 11181665 Clinical Trial.
Phase I trial and pharmacologic trial of sequences of paclitaxel and topotecan in previously treated ovarian epithelial malignancies: a Gynecologic Oncology Group study.
O'Reilly S, Fleming GF, Barker SD, Walczak JR, Bookman MA, McGuire WP 3rd, Schilder RJ, Alvarez RD, Armstrong DK, Horowitz IR, Ozols RF, Rowinsky EK. O'Reilly S, et al. Among authors: horowitz ir. J Clin Oncol. 1997 Jan;15(1):177-86. doi: 10.1200/JCO.1997.15.1.177. J Clin Oncol. 1997. PMID: 8996140 Clinical Trial.
Analysis for steroid production of a Sertoli-Leydig cell tumor.
Sainz de la Cuesta R, Rock JA, Homsi R, Symonds DA, Horowitz IR. Sainz de la Cuesta R, et al. Among authors: horowitz ir. Gynecol Oncol. 1994 Feb;52(2):276-80. doi: 10.1006/gyno.1994.1046. Gynecol Oncol. 1994. PMID: 8314152
Epidemiology of adenocarcinoma of the cervix.
Horowitz IR, Jacobson LP, Zucker PK, Currie JL, Rosenshein NB. Horowitz IR, et al. Gynecol Oncol. 1988 Sep;31(1):25-31. doi: 10.1016/0090-8258(88)90265-x. Gynecol Oncol. 1988. PMID: 3410353
67 results